2026 / 05 / 05
PharmaEssentia Included in the Dow Jones Best-in-Class Indices (DJBIC) as Taiwan’s Sole Pharmaceutical and Biotechnology Representative
PharmaEssentia has been selected as a constituent of the Dow Jones Best-in-Class Indices (DJBIC), becoming the sole Taiwanese biopharmaceutical company included in its industry category. This recognition highlights the Company’s commitment to sustainable growth, transparent governance, and long-term stakeholder value creation.
